Franchise opportunities compared
Medicap Pharmacy vs NexGenEsis Healthcare
Reviewed figures from each brand's Franchise Disclosure Document (FDD), side by side. Each figure carries its FDD year and page. This is not a ranking or recommendation, and the two FDDs may cover different years and location groups.
Initial investment · Item 7
Medicap Pharmacy
$130,000 – $546,653
2025 FDD · Item 7NexGenEsis Healthcare
$124,500 – $362,695
2025 FDD · Item 7Initial franchise fee · Item 5
Medicap Pharmacy
$0.00
2025 FDD · Item 5 · PDF p. 18NexGenEsis Healthcare
Not available
Royalty · Item 6
Medicap Pharmacy
3%
2025 FDD · Item 6 · PDF p. 19NexGenEsis Healthcare
$7.00
2025 FDD · Item 6 · PDF p. 19Before you compare
- Both sets of figures come from 2025 FDDs.
- Medicap Pharmacy and NexGenEsis Healthcare disclose more than one business format, so the investment range spans formats; the full report breaks them out.
- Only NexGenEsis Healthcare has reviewed Item 19 figures here.
Financial commitment
Medicap Pharmacy
NexGenEsis HealthcareMedicap Pharmacy
NexGenEsis Healthcare
Medicap Pharmacy
NexGenEsis Healthcare
Medicap Pharmacy
NexGenEsis Healthcare
Medicap Pharmacy
NexGenEsis Healthcare
System scale & health
Medicap Pharmacy
NexGenEsis HealthcareMedicap Pharmacy
NexGenEsis Healthcare
Medicap Pharmacy
NexGenEsis Healthcare
Medicap Pharmacy
NexGenEsis Healthcare
Medicap Pharmacy
NexGenEsis Healthcare
Medicap Pharmacy
NexGenEsis Healthcare
Financial performance (Item 19), by location group
Medicap PharmacyNot disclosed — no Item 19 financial performance representation
NexGenEsis HealthcareItem 19 groups are shown separately and never combined. Revenue or sales figures are not profit. Net outlet change and turnover are Franopolis calculations from the disclosed counts; turnover is a count-based rate, not a measure of owner earnings.
Medicap Pharmacy vs NexGenEsis Healthcare: common questions
- Which costs less to open, Medicap Pharmacy or NexGenEsis Healthcare?
- Medicap Pharmacy: $130,000 – $546,653 (2025 FDD · Item 7); NexGenEsis Healthcare: $124,500 – $362,695 (2025 FDD · Item 7). These are each franchisor's Item 7 estimated initial investment. The low end of the disclosed estimate is lower for NexGenEsis Healthcare. At least one range spans several business formats. Estimates are not quotes, and the FDD years may differ.
- How do Medicap Pharmacy and NexGenEsis Healthcare royalties compare?
- Medicap Pharmacy: 3% (2025 FDD · Item 6 · PDF p. 19); NexGenEsis Healthcare: $7.00 (2025 FDD · Item 6 · PDF p. 19). Royalties as disclosed in Item 6; other recurring fees are listed separately.
- Which has more locations, Medicap Pharmacy or NexGenEsis Healthcare?
- Medicap Pharmacy: 59 (2025 FDD · Item 20 · PDF p. 48); NexGenEsis Healthcare: 14 (2025 FDD · Item 20 · PDF p. 65). Total outlets from Item 20. Outlet counts do not indicate territory availability or franchisee results.
- Do Medicap Pharmacy and NexGenEsis Healthcare disclose financial performance (Item 19)?
- Medicap Pharmacy makes no Item 19 financial performance representation; NexGenEsis Healthcare has reviewed Item 19 figures for 3 location groups. Different location groups are not directly comparable, and revenue is not profit.
Answers restate the reviewed figures above. Not a ranking or recommendation.
Keep researching

Full Medicap Pharmacy report
Every reviewed fee, Item 19 group, outlet table and territory disclosure

Full NexGenEsis Healthcare report
Every reviewed fee, Item 19 group, outlet table and territory disclosure



